Cannabis Law Report

APRIL 28, 2022

FORT LAUDERDALE, Fla. , April 28, 2022 /PRNewswire/ — Psychedelic Invest ( PsychedelicInvest.com ), an online resource educating stakeholders about the burgeoning psychedelic medicine industry, is pleased to announce the launch of the Psychedelic Invest Podcast. Hadas Alterman : Founding Partner at Plant Medicine Law Group.

Data 59

Data Education Medicine Media 59

Cannabis Law Report

AUGUST 27, 2021

The Board will further serve as a resource for media, other medical associates and general audiences interested in the science behind psychedelic wellness and treatments. He has been an advocate for the use of psychedelics in medicine and donated to the cause for the last 10 years. Chris Ray , PhD : Interventional Pain Physician.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

DECEMBER 4, 2019

Based on her data, Dr. Snyder finds that requiring “Total THC” concentrations not to exceed 0.3%, rather than just limiting ?9-THC, This data shows that 97.4% (370 out of 380) samples fell at or below the 0.3% Dr. Snyder taught at Harvard University School of Medicine. 9-THC, severely limits the hemp strains a farmer can grow.

Data 59

Data THC Strains Concentrates 59

SpeedWeed

JULY 25, 2021

Here are the applicants and their scores with notable MSO losses in red text: Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media. Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media.

Media 52

Media Data Dispensary Access 52

Cannabis Law Report

JULY 24, 2019

Dr Mikael Sodergren , Managing Director and Academic Lead at Sapphire Medical Clinics said: “Medicinal cannabis is a new and exciting field. We have the expertise to prescribe medicinal cannabis in a way that fits in with other more conventional treatments as and when we judge that to be in the best interest of the patients.

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

Cannabis Law Report

JULY 22, 2021

“By acquiring traditional healthcare assets and subsequently layering in alternative medicines and psychedelic therapies as regulations develop, Levitee will have direct and immediate access to a much broader patient population. Levitee Media Contact. media@leviteelabs.com. Forward-Looking Statements. ir@leviteelabs.com.

eCommerce 105

eCommerce Therapy Media Access 105

Cannabis Law Report

JANUARY 24, 2022

Accomplished leader to oversee Goldfinch Bio’s clinical function to advance precision medicines for people living with kidney disease. Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. CAMBRIDGE, Mass.–(BUSINESS

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

DECEMBER 9, 2021

9, 2021 /PRNewswire/ — Mind Medicine (MindMed) Inc. MindMed is a clinical-stage psychedelic medicine biotech company that seeks to discover, develop and deploy psychedelic-inspired medicines and therapies to address addiction and mental illness. Thu, December 9, 2021, . NEW YORK , Dec. ” About MindMed.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

JULY 6, 2021

Professor Johnson also received national media attention for his appearance in the Home Box Office (HBO) original documentary feature, “Addiction”, which won the prestigious Governors Award, a special Emmy Award, from the Academy of Television Arts and Sciences. In 2019, Dr. Johnson received the R. Ben Kaplan, CEO of Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

JULY 9, 2021

The Index is designed to provide exposure to the performance of North American publicly-listed life sciences companies focused on psychedelic medicines, and other companies with business activities in the psychedelics industry. SOURCE Horizons ETFs Management ( Canada ) Inc. 416) 640-2956, jmcguire@horizonsetfs.com. Related Links.

Data 105

Data Clinical Trials Decriminalization Hemp 105

Cannabis Law Report

OCTOBER 15, 2021

The presentation details the identification of a novel locus on chromosome 14 which is associated with proteinuric kidney disease and includes data which confirms the well-known association of APOL1 risk haplotypes (i.e., New data supporting the use of machine learning and electronic health records to predict DN in patients with diabetes. “In

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

Medicinal Genomics

JUNE 17, 2021

First, we are certain the “commercially available” assays the authors used were not Medicinal Genomics kits. We make this conclusion based on the information provided in the supplemental data and the fact that our kits solve for many of the performance issues the authors experienced. More on that below. Join Our Webinar to Learn More.

Medicine 52

Medicine Media Data Cannabis 52

Cannabis Law Report

DECEMBER 6, 2021

–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Jeff W. Jacobs, Ph.D. as Chief Scientific Officer (CSO). Dr. Jacobs, who most recently served as CSO of Ardelyx, Inc.,

Research and Development 52

Research and Development Supply Chain Clinical Trials Medicine 52

The Cannigma

OCTOBER 22, 2023

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data 88

Data Research and Development Sleep Collective 88

Cannabis Law Report

JUNE 17, 2021

CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ( “Entheon” ), a biotechnology company focused on developing psychedelic medicines to treat addiction, and Silo Wellness Inc. For Entheon media inquiries, please contact Crystal Quast at: Bullseye Corporate. . – June 17, 2021) – Entheon Biomedical Corp. Crystal Quast.

Research and Development 75

Research and Development Access Therapy Media 75

Cannabis Law Report

NOVEMBER 18, 2021

The Global Drug Policy Index is composed of 75 policy indicators running across 5 dimensions: the absence of extreme responses, the proportionality of the criminal justice system, health and harm reduction, access to controlled medicines and development. Each country is then given a total score ranging from 0 to 100. How did it come to be?

Policy 52

Policy Data Media Access 52

Cannabis Law Report

NOVEMBER 9, 2021

Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a modern world, today announced the official, completed acquisition of Ketamine Wellness Centers Arizona LLC (“KWC”), becoming the largest chain of wellness centers providing ketamine treatments in the U.S.

Treatment 52

Treatment Therapy Media Access 52

SpeedWeed

MARCH 2, 2021

When we founded Cannabiz Media, our choice was to focus exclusively on cannabis licenses, companies, and contacts. Most bristled that Trulieve is out of state, and that new date would delay medicine getting to all the patients that need it. These licenses are expected to be issued in late spring or early summer.

Media 52

Media Seed-To-Sale Oil Business 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? Recent data suggest the US science knowledge is about the global average.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JUNE 30, 2021

Industrial hemp can be processed into over 50,000 uses, including fuels, plastics, graphene, solvents, building materials, foods, and medicines, and is also a powerful tool in the global effort to combat climate change because an acre of hemp can potentially sequester as much or more carbon as an acre of rainforest. Media: Pamela Hanratty.

Hemp 105

Hemp Agriculture Media THC 105

Veriheal

AUGUST 17, 2021

In an official statement to media sources, Dr. Drake said ; “We don’t find any evidence to support the theory that cannabis functions as a gateway drug… if anything, we find that recreational cannabis legalization decreases opioid-related emergency department visits.” Marijuana is a gateway drug, really?

Data 98

Data Cannabis Media Collective 98

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

If you are considering trying legal medicinal or recreational cannabis, it is important to get the facts regarding its potential side effects. was created to perpetuate this stereotype, the federal government had initiated a federal ban, and media portrayal of its so-called ill-effects helped convince many legislators to vote in its favor.

Marijuana 52

Marijuana Research and Development Sleep Strains 52

Cannabis Law Report

DECEMBER 14, 2021

(NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today that it is the first company to formulate medical cannabis extract vaporizer pen products in a UK-based manufacturing premises, licensed and approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Home Office.

Extraction 52

Extraction Patients Medicine Tincture 52

Cannabis Law Report

JUNE 1, 2021

Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. Medicine Man Technologies, Inc. The corporate entity continues to be named Medicine Man Technologies, Inc. SOURCE Medicine Man Technologies, Inc.

Seed-To-Sale 85

Seed-To-Sale Cultivation Events Strains 85

Cannabis Law Report

JULY 20, 2019

Marijuana is legal for both recreational and medicinal purposes in California, but it is still illegal under federal law. According to a brief published by the National Association of Federally-Insured Credit Unions, FinCEN data showed that 633 depository institutions provided banking services to MRBs as of March 31.

Banking 40

Banking Data Media Business 40

Cannabis Law Report

SEPTEMBER 15, 2021

The FDA is aware of media reports of delta-8 THC products getting consumers “high.” To report adverse events in animals to the FDA’s Center for Veterinary Medicine, please download and submit Form FDA 1932a found at: www.fda.gov/ReportAnimalAE. Findings based on NPDS data do not necessarily reflect the opinions of AAPCC.

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

MAY 6, 2022

The FDA’s warning letters tell the public that the FDA reads and reviews companies’ websites, labels, social media, and marketing language. The FDA evaluates sellers’ claims, graphics, and product descriptions – including products marketed for animals, information about food additives, and social media websites.

THC 52

THC CBD Media Food 52

Freedom Leaf

JANUARY 4, 2018

After months of development, my partner and I built and successfully launched the beta for our cannabis data-analytics software, Jade Insights. It’s a software platform that helps cannabis businesses augment their process by providing insights for data-backed decision-making. ” JOHN KAGIA. ” OPHELIA CHONG.

Data 60

Data Policy Media Cannabis 60

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Media Enquiries: Sam Brown Inc.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Medicinal Genomics

FEBRUARY 20, 2019

Recently, Oregon CBD made a statement on its social media accounts, calling for the end of male hemp cultivation outdoors in Oregon and other areas that are currently devoid of feral hemp populations. appeared first on Medicinal Genomics. Gender is a controversial topic in hemp cultivation. Stock up now for spring planting!

Hemp 100

Hemp Cultivation Cannabinoids CBD 100

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. These treatments can be prescribed only by specialist doctors in a limited number of circumstances where other medicines have failed. Recreational use of cannabis remains illegal.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

SpeedWeed

MARCH 7, 2021

In the latest episode of the Cannacurio Podcast from Cannabiz Media, my co-host, Amanda Guerrero, and I discuss license updates coming to the Cannabiz Media License Database, including Oregon cannabis licenses, Louisiana CBD licenses, and Pennsylvania, Ohio, Montana and South Carolina hemp licenses. ‍ Ed Keating : Hi Amanda.

Extraction 52

Extraction Data Hemp Research and Development 52

Cannabis Law Report

JULY 28, 2021

Active research includes applications of machine learning and data mining as a member of the University of Alberta computational psychiatry group. For media inquiries, please contact Crystal Quast at: Bullseye Corporate. . – July 28, 2021) – Entheon Biomedical Corp. Joseph Cullen, Investor Relations. Crystal Quast.

Research and Development 105

Research and Development Events Media Data 105

Veriheal

AUGUST 12, 2021

Funded by Realm of Caring —a non-profit organization committed to redefining cannabis through research and education—this study on CBD and epilepsy was carried out as part of a joint effort with Johns Hopkins University School of Medicine researchers. A specific type of CBD was focused on for the investigation.

Epilepsy 66

Epilepsy Pharmaceutical Patients Sleep 66

CannaMD

NOVEMBER 6, 2019

Perhaps the commercialization of marijuana and the favorable media coverage surrounding the health effects of marijuana are fostering such a perception. Results further indicate that the presence of medicinal cannabis legislation appears to have no influence over opioid misuse. Marijuana Preferred Over Pain Pills. million to 11.4

Marijuana 87

Marijuana Patients Clinical Trials Data 87

Medicinal Genomics

SEPTEMBER 27, 2018

Medicinal Genomics feels this is a significant liability for the cannabis industry as a whole. Within this blog post, we have identified the statements included in the Analytical Cannabis article that Medicinal Genomics knows to be false, those that are true, as well as supplemental data on our position on each specific issue.

Food 69

Food Data Safety Patients 69